Etubics Corporation, based in Seattle, Wash., is a next generation clinical stage bio-pharmaceutical company. The Company is developing the next generation in vaccines and immunotherapies, utilizing a patented advanced generation adenovirus delivery platform and a validated manufacturing human cell line, collectively the Etubics Platform. The Company’s products have been developed to overcome three significant limitations associated with existing adenovirus based products: i) ineffectiveness in the presence of pre-existing immunity; ii) inability to immunize multiple times against the same disease; and, iii) inability to immunize against multiple diseases in the same person. Benefits of the Etubics Platform products include the following: • Safe and Thoroughly Studied including human trials • Effective in the Presence of Pre-Existing Immunity • CMI Response • Rapid Development • Diverse Product Opportunities The Company has completed Phase I/IIa clinical trials with its lead product, ETBX-011 an immunotherapeutic to treat colorectal cancer. To date, the Company has been very encouraged by the clinical data for ETBX-011 and no safety issues or serious adverse effects (SAE) have been reported in both animal and human studies.
| Website | http://www.etubics.com |
| Revenue | $1 million |
| Employees | 8 (6 on RocketReach) |
| Founded | 2005 |
| Address | 410 W Harrison St Ste 200, Seattle, Washington 98119, US |
| Phone | +1 408-732-2400 |
| Fax | (206) 838-2978 |
| Industry | Biotechnology, Chemicals, Petrochemicals, Glass & Gases, Other Devices and Supplies, Manufacturing, Science and Engineering, Other Pharmaceuticals and Biotechnology, Health Care |
| Competitors | Johnson & Johnson, Pfizer, Sanofi, GSK, AstraZeneca, Moderna Therapeutics, BioNTech SE, Emergent BioSolutions, Novavax, CureVac +37 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325414 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Etubics employee's phone or email?
Etubics Questions
The Etubics annual revenue was $1 million in 2026.
Frank Jones is the Chairman and Chief Executive Officer of Etubics.
6 people are employed at Etubics.
Etubics is based in Seattle, Washington.
The NAICS codes for Etubics are [32541, 3254, 325414, 325, 32].
The SIC codes for Etubics are [28, 283].
Top Etubics Employees
-
Frank Jones
Chairman and Chief Executive Officer at Etubics
Seattle, WA, US15+ -
Adrian Rice
Vice President, Research at Etubics
Seattle, WA, US15 -
Joseph Balint
Scientist at Etubics
Seattle, WA, US2 -
Amadou Bah
Ingeniere at Etubics
Montreal, QC, CA25+
Related Companies
